Regulatory Aspects of Nanomedicine in Europe
In: CLINICAL NANOMEDICINE- FROM BENCH TO BEDSIDE, Raj Bawa, Gerald F. Audette, Israel Rubinstein, eds., Pan Stanford Publishing, Singapore, 2012
17 Ergebnisse
Sortierung:
In: CLINICAL NANOMEDICINE- FROM BENCH TO BEDSIDE, Raj Bawa, Gerald F. Audette, Israel Rubinstein, eds., Pan Stanford Publishing, Singapore, 2012
SSRN
In: European journal of risk regulation: EJRR ; at the intersection of global law, science and policy, Band 2, Heft 1, S. 85-91
ISSN: 2190-8249
Attempts at suitable identification of a generally accepted definition of a 'nanomaterial' have been going on in Europe and worldwide for some time. Definitions are important from a regulatory perspective as "they assist in establishing the subject matter and scope of what is to be regulated". However, considering the complexities associated with nanoscience and also the differing opinions on various definitions, this has not been an easy task. Reaching an agreement on fundamental terms and definitions such as 'nanotechnology', 'nanoparticle', 'nanoscale', and a 'nanomaterial' is both complex and contested. To date, there is no internationally recognised and accepted definition of a 'nanomaterial' even though several definitions have been discussed and proposed by national authorities, scientific committees, international organisations, and other bodies.
In: European Journal of Risk Regulation, Band 2, Heft 1, S. 79-85
SSRN
In: NanoEthics, Band 5, Heft 2, S. 245-247
SSRN
SSRN
Working paper
In: NANOTECHNOLOGY – OPPORTUNITIES AND CHALLENGES, pp. 36-56, S. Zodgekar, ICFAI Press, 2008
SSRN
In: Cochin University Law Review, Band 29, Heft 3, S. 262-277
SSRN
In: Innovation: the European journal of social science research, Band 22, Heft 1, S. 125-142
ISSN: 1469-8412
In: Innovation: The European Journal of Social Science Research, Band 22, Heft 1, S. 125-142
SSRN
In: NANOTECHNOLOGY COMMERCIALISATION, Takuya Tsuzuki, ed., Pan Stanford, 2011
SSRN
In: QUANTUM ENGAGEMENTS: SOCIAL REFLECTIONS OF NANOSCIENCE AND EMERGING TECHNOLOGIES, pp. 139-150, Zülsdorf T, Coenen C, Ferrari A, et al., eds., IOS Press, Forthcoming
SSRN
In: European journal of risk regulation: EJRR ; at the intersection of global law, science and policy, Band 1, Heft 4, S. 420-427
ISSN: 2190-8249
This section is meant to give readers an insight into the emerging field of nanotechnologies and risk regulation. It informs and updates readers on the latest European and international developments in nanotechnologies and risk regulation across different sectors (e.g., chemicals, food, cosmetics, pharmaceuticals) and policy areas (e.g., environmental protection, occupational health and consumer product, food and drug safety). The section analyzes how existing regulatory systems deal with new kinds of risks and reviews recent regulatory developments with a focus on how best to combine scientific freedom and technological progress with a responsible development and commercialization of nanotechnologies.
In: Studies in Ethics, Law, and Technology, Vol. 4, No. 2, 2010
SSRN
In: European journal of risk regulation: EJRR ; at the intersection of global law, science and policy, Band 1, Heft 2, S. 115-122
ISSN: 2190-8249
Consumer desire for superior and new products has provided industry with the opportunity and market demand to incorporate and experiment with new technologies, including nanotechnologies. While these products and processes have fallen under the scope of existing regulatory frameworks, potential health and safety concerns has prompted some stakeholders to call for new, nano-specific regulations. Until now, governments have been hesitant to respond to such demands given the evolving state of the scientific art and limited international agreement as to what nanotechnologies or nanomaterials "are". Despite these challenges, in November 2009 the European Union formally embraced the idea of specifically regulating the use of nanomaterials in cosmetic formulations. To achieve this objective, the Parliament and Council had to define what they meant by nanomaterials within the context of the adopted text in order to regulate them. It appears likely that other instruments will be similarly amended so as to include nano-specific provisions, including definitions. This article explores this policy shift within the European Union and the implications of the Parliament and Council's stance at this stage due to the absence of a generally accepted definition within the international community.
In: European Journal of Consumer Law, Band 1, S. 85-113
SSRN